The first transgenic fish model of an intestinal tumor was developed through the expression of the H. pylori virulence factor cagA, which was in turn controlled by the 1.6-kb FABP2 promoter in tp53 mutant background zebrafish (tp53M214K) [51]. The gene discussed is TP53; the disease is intestinal neoplasm.